| Date | Form | Description | Docs | XBRL | Pages |
| 02/09/26 | 8-K | Current report |
|
|
6 |
| 01/29/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/28/26 | DEF 14A | Definitive proxy statements |
|
|
34 |
| 01/12/26 | S-8 | Securities to be offered to employees in employee benefit plans |
|
|
23 |
| 01/12/26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
|
|
38 |
| 01/06/26 | SCHEDULE 13D/A | General Statement of Acquisition of Beneficial Ownership |
|
3 | |
| 01/06/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/06/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/06/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/06/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Read More...